DUPIXENT is a medicine that is administered by subcutaneous injection and is intended for use under the guidance of a healthcare provider.1

  • Patients may self-inject DUPIXENT—or a caregiver may administer DUPIXENT—after training has been provided by a healthcare provider on proper subcutaneous injection technique using the pre-filled syringe or pen
  • It is important to provide proper training to patients and/or caregivers on the preparation and administration of DUPIXENT prior to use
  • After administration, advise patients to follow sharps disposal recommendations
  • Patients and/or caregivers should read the Instructions for Use prior to injecting

ADULTS (18+) Years
Inadequately Controlled CRSwNP1

18+ YEARS

Every 2 weeks
300mga
1 pre-filled pen or syringeNO LOADING DOSE

a 300 mg=2 mL solution.

Two Administration Options for You and Your Patients

PRE-FILLED PEN
 

SUBCUTANEOUS AUTOINJECTOR
WITH HIDDEN NEEDLE
NEEDLE CAP IS NOT MADE
WITH NATURAL RUBBER LATEX
VISUAL AND AUDIBLE FEEDBACK
AVAILABLE IN 300 mg (SHOWN HERE) AND 200 mg

Important Administration Instructions2,3

  • Patients should read the Instructions for Use prior to injecting
  • Administer the subcutaneous injection into the thigh or abdomen, except for the 2 inches (5 cm) around the navel
  • The upper arm can also be used if a caregiver administers the injection
  • Rotate the injection site with each injection. DO NOT inject DUPIXENT into skin that is tender, damaged, bruised, or scarred
  • If a dose is missed, instruct the patient to administer the injection within 7 days from the missed dose and then resume their original schedule. If the missed dose is not administered within 7 days, instruct the patient to wait until the next dose on the original schedule

Preparation for Use1

Before injection, instruct patients and/or caregivers to remove DUPIXENT from the refrigerator and allow DUPIXENT to reach room temperature without removing the needle cap.

  • 45 minutes for the 300 mg/2 mL pre‑filled syringe or pre-filled pen

Patients and/or caregivers should inspect DUPIXENT for particulate matter and discoloration prior to administration.

  • Do not use if the liquid contains visible particulate matter or is discolored or cloudy (other than clear to slightly opalescent, colorless to pale yellow)

Patients and/or caregivers should discard any unused product remaining in the pre‑filled syringe or pre-filled pen in accordance with local requirements.

Storage and Handling1

  • DUPIXENT is sterile and preservative‑free. Patients and/or caregivers should discard any unused portion
  • Patients and/or caregivers should store DUPIXENT by refrigerating at 36 °F to 46 °F (2 °C to 8 °C) in the original carton to protect from light
  • If necessary, DUPIXENT may be kept at room temperature up to 77 °F (25 °C) for a maximum of 14 days. DUPIXENT should not be stored above 77 °F (25 °C). After removal from the refrigerator, DUPIXENT must be used within 14 days or discarded
  • DUPIXENT should not be exposed to heat or direct sunlight
  • Do NOT freeze. Do NOT shake
  • Any unused medicinal product or waste material should be disposed of in accordance with local requirements
DUPIXENT MyWay®
Get patient access support and information about benefits investigations, prior authorizations, and medical necessity and appeal letters.
EXPLORE PATIENT SUPPORT RESOURCES